Sean P. Nolan, Director at Taysha Gene Therapies, Inc. (TSHA), bought 1,170 shares at $22.35 ($26K) on 2021-05-20, disclosed to the SEC on 2021-05-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AVXS | SELL | 2018-03-09 | $1.3M | — | Filing → |
| ITMN | SELL | 2014-08-14 | $850K | — | Filing → |
| ITMN | SELL | 2014-06-20 | $471K | — | Filing → |